Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

NEUROCRINE BIOSCIENCES INC

NBIX · Nasdaq · CIK 0000914475 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

84 Form 4 transaction lines observed in the same window
30 sales · 54 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Delaet IngridChief Regulatory Officer
○▼○▼○▼○▼○▼○○
Onyia JudeChief Scientific Officer
○▼○▼○○○○
Lippoldt DarinChief Legal Officer
○▼○▼○▼○○
Boyer David W.Chief Corp. Affairs Officer
▼○○▼
Keswani Sanjay ChandruChief Medical Officer
○○○○
SHERWIN STEPHEN ADirector
○○▼○
● Purchase▼ Sale○ Other

Showing the six most active owners; 7 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
40Sales
159Other Form 4 lines
70SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING30 sale line(s) · context only
OTHER54 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
5,853,128
Previous report
4,964,907
Avg daily volume
1,476,037
Days to cover
4.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

199 transaction lines in the latest 365-day window; 879 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-14Boyer David W.Sale (S)Common Stock826USD 157.45USD 130,054SEC filing ↗
2026-09-14ABERNETHY MATTSale (S)Common Stock2,311USD 157.20USD 363,289SEC filing ↗
2026-09-11Onyia JudeTax withholding (F)Common Stock1,936USD 156.22USD 302,442SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-14Boyer David W.Sale (S)Common Stock826USD 157.45USD 130,054SEC filing ↗
2026-09-14ABERNETHY MATTSale (S)Common Stock2,311USD 157.20USD 363,289SEC filing ↗
2026-09-11Onyia JudeTax withholding (F)Common Stock1,936USD 156.22USD 302,442SEC filing ↗
2026-09-11Onyia JudeAward / grant (A)Common Stock3,587USD 0.00USD 0SEC filing ↗
2026-09-11Lippoldt DarinTax withholding (F)Common Stock2,419USD 156.22USD 377,896SEC filing ↗
2026-09-11Lippoldt DarinAward / grant (A)Common Stock4,483USD 0.00USD 0SEC filing ↗
2026-09-11Keswani Sanjay ChandruTax withholding (F)Common Stock2,112USD 156.22USD 329,937SEC filing ↗
2026-09-11Keswani Sanjay ChandruAward / grant (A)Common Stock3,914USD 0.00USD 0SEC filing ↗
2026-09-11Gano KyleTax withholding (F)Common Stock4,380USD 156.22USD 684,244SEC filing ↗
2026-09-11Gano KyleAward / grant (A)Common Stock8,117USD 0.00USD 0SEC filing ↗
2026-09-11GORMAN KEVIN CHARLESTax withholding (F)Common Stock7,839USD 156.22USD 1,224,609SEC filing ↗
2026-09-11GORMAN KEVIN CHARLESAward / grant (A)Common Stock14,343USD 0.00USD 0SEC filing ↗
2026-09-11Delaet IngridTax withholding (F)Common Stock2,419USD 156.22USD 377,896SEC filing ↗
2026-09-11Delaet IngridAward / grant (A)Common Stock4,483USD 0.00USD 0SEC filing ↗
2026-09-11Cooke JulieTax withholding (F)Common Stock1,936USD 156.22USD 302,442SEC filing ↗
2026-09-11Cooke JulieAward / grant (A)Common Stock3,587USD 0.00USD 0SEC filing ↗
2026-09-11Boyer David W.Tax withholding (F)Common Stock1,936USD 156.22USD 302,442SEC filing ↗
2026-09-11Boyer David W.Award / grant (A)Common Stock3,587USD 0.00USD 0SEC filing ↗
2026-09-11BENEVICH ERICTax withholding (F)Common Stock3,386USD 156.22USD 528,961SEC filing ↗
2026-09-11BENEVICH ERICAward / grant (A)Common Stock6,275USD 0.00USD 0SEC filing ↗
2026-09-11ABERNETHY MATTTax withholding (F)Common Stock2,709USD 156.22USD 423,200SEC filing ↗
2026-09-11ABERNETHY MATTAward / grant (A)Common Stock5,020USD 0.00USD 0SEC filing ↗
2026-09-09BENEVICH ERICSale (S)Common Stock2,154USD 154.61USD 333,030SEC filing ↗
2026-09-09BENEVICH ERICOption exercise / conversion (M)Common Stock3,194USD 43.24USD 138,109SEC filing ↗
2026-09-02SHERWIN STEPHEN AGift (G)Common Stock1,000USD 0.00USD 0SEC filing ↗
2026-08-04Onyia JudeGift (G)Common Stock2,409USD 0.00USD 0SEC filing ↗
2026-07-29Norwalk Leslie VOption exercise / conversion (M)Common Stock842USD 139.43USD 117,400SEC filing ↗
2026-07-28Norwalk Leslie VSale (S)Common Stock1,250USD 182.01USD 227,512SEC filing ↗
2026-07-10Delaet IngridSale (S)Common Stock4,367USD 181.02USD 790,514SEC filing ↗
2026-07-10Delaet IngridOption exercise / conversion (M)Common Stock4,367USD 106.02USD 462,989SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerNBIX
CIK0000914475
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history879 transaction lines from 2020-01-08 to 2026-09-14
0 P purchase lines · 506 S sale lines · 373 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.